Latest Safety News

Cynata Therapeutics reports encouraging Phase 1 results for its diabetic foot ulcer treatment CYP-006TK, alongside a strengthened balance sheet and ongoing clinical progress.

OncoSil Medical has secured new distribution agreements across key international markets and achieved critical regulatory milestones, while raising $8 million to fuel its growth in pancreatic cancer treatment.

LTR Pharma reports compelling clinical results for its nasal spray ED treatment SPONTAN®, demonstrating rapid absorption and strong safety, alongside strategic partnerships and a robust $34 million cash position.

Sandfire Resources reported a 5% increase in copper equivalent production for H1 FY25, alongside a reduction in injury rates and operating costs at its Motheo operation. The company secured key approvals for a new tailings facility at MATSA, underpinning long-term growth.

Bio-Gene Technology Limited has advanced its bio-insecticide pipeline with two U.S. Department of Defense grants totaling A$3 million, alongside key regulatory and production milestones for Flavocide® and Qcide®.

Biome Australia Limited has announced encouraging results from functional studies on its probiotic strain BMB18, highlighting its potential to modulate immune responses, reduce inflammation, and support intestinal health. These findings pave the way for targeted clinical research and product innovation.

Island Pharmaceuticals reports promising safety and anti-dengue activity in its Phase 2a trial of ISLA-101 and has commenced the Phase 2b therapeutic arm, backed by a fresh A$3.5 million capital raise.

Zimplats' December quarter report reveals a decline in mined and milled volumes alongside increased cash costs per 6E ounce, even as key expansion projects advance steadily.

Arafura Rare Earths has secured a pivotal A$200 million investment commitment from the National Reconstruction Fund Corporation, advancing its Nolans Project towards a final investment decision targeted for mid-2025.

Black Cat Syndicate has completed refurbishment and commenced commissioning at its Paulsens Gold Operation, supported by a successful $80 million capital raising that strengthens its balance sheet and growth prospects.

Carawine Resources Limited has progressed exploration planning across key Australian projects while navigating a significant compulsory acquisition dispute initiated by major shareholder QGold.

Belararox Limited has commenced a significant diamond drilling campaign at its TMT Project in Argentina, supported by a recent A$8.88 million capital raise that underpins its 2025 exploration programs across Argentina and Botswana.